Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?

Eur J Vasc Endovasc Surg. 2006 Sep;32(3):286-93. doi: 10.1016/j.ejvs.2006.03.009. Epub 2006 May 11.

Abstract

Aims: To determine whether statins can reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery.

Methods: A search using Pubmed was performed to identify reports in English. The search terms were: "statins", "perioperative morbidity", "perioperative mortality" and "vascular surgery". We excluded studies dealing with the effect of statins in cardiac surgery. Retrieved articles were manually searched.

Results: Current evidence shows that statins decrease perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery. Any benefit probably occurs soon (within a month) after initiating treatment.

Conclusions: Appropriately designed trials need to confirm the beneficial effect of perioperative statin therapy in various patient categories. The optimal duration and dose of perioperative statin therapy should be defined.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aortic Aneurysm, Abdominal / mortality
  • Aortic Aneurysm, Abdominal / surgery
  • Arterial Occlusive Diseases / mortality
  • Arterial Occlusive Diseases / surgery
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Metoprolol / therapeutic use
  • Morbidity
  • Multivariate Analysis
  • Vascular Surgical Procedures / adverse effects*
  • Vascular Surgical Procedures / mortality*

Substances

  • Adrenergic beta-Antagonists
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Metoprolol